- Home
- Medical
- Gynecology & Obstetrics
- Noninvasive Molecular Markers in Gynecologic Cancers
Noninvasive Molecular Markers in Gynecologic Cancers
List Price:
$94.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Debmalya Barh, Mehmet Gunduz
Format:
Paperback
Pages:
516
Publisher:
CRC Press (January 29, 2024)
Language:
English
ISBN-13:
9781138749504
Dimensions:
7" x 10"
File:
TAYLORFRANCIS-TayFran_260411045344499-20260411.xml
Folder:
TAYLORFRANCIS
List Price:
$94.99
As low as:
$90.24
Publisher Identifier:
P-CRC
Discount Code:
H
Audience:
Professional and scholarly
Country of Origin:
United States
Weight:
33.625oz
Pub Discount:
30
Imprint:
CRC Press
Case Pack:
1
Overview
In cancer treatment, non-invasive diagnosis can avoid complications of biopsy and other unfavorable impacts on patient's health. DNA, methylation, SNPs, miRNA, mRNA, protein, autoantibodies, metabolite, and Omics-based markers from remote media such as blood, plasma, and urine are emerging as noninvasive molecular markers with high specificity and sensitivity towards many cancers. In many instances, these markers are also emerging as next-generation personalized diagnostics and targets or therapeutics for personalized cancer treatment. This book classifies the available molecular tumor markers according to their principal characteristics and relative methodologies.
